Results 191 to 200 of about 189,528,022 (311)
Dominant Leg Continuous Unilateral Hopping Impairs Contralateral Leg But Not Upper Body Explosive Performance. [PDF]
Sardroodian M, Rahmani H, Behm DG.
europepmc +1 more source
ABSTRACT Background X‐linked adrenoleukodystrophy (X‐ALD) is a neurometabolic disorder caused by pathogenic variants in ABCD1, leading to slowly progressive spinal cord disease in nearly all affected men. Sensitive biomarkers to quantify disease severity and predict progression are needed for clinical care and trial design.
Eda G. Kabak +4 more
wiley +1 more source
The reliability and operational test system of a power grid with large-scale renewable integration
Jianxue Wang +3 more
doaj +1 more source
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio +8 more
wiley +1 more source
Test of a PV Module Under Installed Condition to Observe Realistic Module Power Output
TONY GAN ANG
doaj +1 more source
Quantification of practice effects in a self-administered online cognitive pre-screening test. [PDF]
Wischmann HA +3 more
europepmc +1 more source
ABSTRACT Objectives Acute kidney injury (AKI) is a common but often underrecognized complication in ischemic stroke patients undergoing mechanical thrombectomy, particularly among those with pre‐existing renal impairment. This study evaluated the incidence, risk factors, and clinical impact of AKI in this high‐risk population.
Michał Borończyk +10 more
wiley +1 more source
A Comparison of Testing Procedures for Detecting Short- and Long-Term Effects of Biomarkers for Cancer Screening. [PDF]
Roy S, Albert PS, Roy A, Liu D.
europepmc +1 more source
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Robust Inference With Ghostknockoffs in Genome-Wide Association Studies With Sample Relatedness. [PDF]
Qi X +5 more
europepmc +1 more source

